Abstract
Tricyclic antidepressant drugs reduce the sensitivity of α2 adrenoceptors during long-term treatment. In the present study, the α2 adrenergic agonist clonidine was administered to 11 depressed patients before and during treatment with the triazolopyridine antidepressant trazodone (TRZ). Clonidine's ability to decrease blood pressure (BP) and plasma levels of the norepinephrine metabolite 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG), and to increase sedation and plasma growth hormone (GH), were measured. TRZ had little effect on these indices of pre- and postsynaptic α2 receptor function, suggesting that the antidepressant properties of TRZ are not related to changes in α2 adrenoceptor sensitivity.
| Original language | English |
|---|---|
| Pages (from-to) | 38-44 |
| Number of pages | 7 |
| Journal | Psychopharmacology |
| Volume | 89 |
| Issue number | 1 |
| DOIs | |
| State | Published - May 1986 |
| Externally published | Yes |
Keywords
- Antidepressants
- Clonidine
- Growth hormone
- MHPG
- Trazodone
- α Adrenoceptors